Preeclampsia, Placental Insufficiency, and Autism Spectrum Disorder or Developmental Delay | Autism Spectrum Disorders | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.186.91. Please contact the publisher to request reinstatement.
1.
Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; Centers for Disease Control and Prevention (CDC).  Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2010.  MMWR Surveill Summ. 2014;63(2):1-21.PubMedGoogle Scholar
2.
Hallmayer  J, Cleveland  S, Torres  A,  et al.  Genetic heritability and shared environmental factors among twin pairs with autism.  Arch Gen Psychiatry. 2011;68(11):1095-1102.PubMedGoogle ScholarCrossref
3.
Stoner  R, Chow  ML, Boyle  MP,  et al.  Patches of disorganization in the neocortex of children with autism.  N Engl J Med. 2014;370(13):1209-1219.PubMedGoogle ScholarCrossref
4.
Hultman  CM, Sparén  P, Cnattingius  S.  Perinatal risk factors for infantile autism.  Epidemiology. 2002;13(4):417-423.PubMedGoogle ScholarCrossref
5.
Glasson  EJ, Bower  C, Petterson  B, de Klerk  N, Chaney  G, Hallmayer  JF.  Perinatal factors and the development of autism: a population study.  Arch Gen Psychiatry. 2004;61(6):618-627.PubMedGoogle ScholarCrossref
6.
Brimacombe  M, Ming  X, Lamendola  M.  Prenatal and birth complications in autism.  Matern Child Health J. 2007;11(1):73-79.PubMedGoogle ScholarCrossref
7.
Gardener  H, Spiegelman  D, Buka  SL.  Prenatal risk factors for autism: comprehensive meta-analysis.  Br J Psychiatry. 2009;195(1):7-14.PubMedGoogle ScholarCrossref
8.
Buchmayer  S, Johansson  S, Johansson  A, Hultman  CM, Sparén  P, Cnattingius  S.  Can association between preterm birth and autism be explained by maternal or neonatal morbidity?  Pediatrics. 2009;124(5):e817-e825.PubMedGoogle ScholarCrossref
9.
Mann  JR, McDermott  S, Bao  H, Hardin  J, Gregg  A.  Pre-eclampsia, birth weight, and autism spectrum disorders.  J Autism Dev Disord. 2010;40(5):548-554.PubMedGoogle ScholarCrossref
10.
Burstyn  I, Sithole  F, Zwaigenbaum  L.  Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada.  Chronic Dis Can. 2010;30(4):125-134.PubMedGoogle Scholar
11.
Dodds  L, Fell  DB, Shea  S, Armson  BA, Allen  AC, Bryson  S.  The role of prenatal, obstetric and neonatal factors in the development of autism.  J Autism Dev Disord. 2011;41(7):891-902.PubMedGoogle ScholarCrossref
12.
Atladóttir  HO, Henriksen  TB, Schendel  DE, Parner  ET.  Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study.  Pediatrics. 2012;130(6):e1447-e1454.PubMedGoogle ScholarCrossref
13.
Shi  L, Fatemi  SH, Sidwell  RW, Patterson  PH.  Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.  J Neurosci. 2003;23(1):297-302.PubMedGoogle Scholar
14.
Zerbo  O, Iosif  AM, Walker  C, Ozonoff  S, Hansen  RL, Hertz-Picciotto  I.  Is maternal influenza or fever during pregnancy associated with autism or developmental delays? results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study.  J Autism Dev Disord. 2013;43(1):25-33.PubMedGoogle ScholarCrossref
15.
Goines  PE, Croen  LA, Braunschweig  D,  et al.  Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: a case-control study.  Mol Autism. 2011;2:13.PubMedGoogle ScholarCrossref
16.
Giulivi  C, Zhang  YF, Omanska-Klusek  A,  et al.  Mitochondrial dysfunction in autism.  JAMA. 2010;304(21):2389-2396.PubMedGoogle ScholarCrossref
17.
Burstyn  I, Wang  X, Yasui  Y, Sithole  F, Zwaigenbaum  L.  Autism spectrum disorders and fetal hypoxia in a population-based cohort: accounting for missing exposures via Estimation-Maximization algorithm.  BMC Med Res Methodol. 2011;11:2.PubMedGoogle ScholarCrossref
18.
Lyall  K, Schmidt  RJ, Hertz-Picciotto  I.  Maternal lifestyle and environmental risk factors for autism spectrum disorders.  Int J Epidemiol. 2014;43(2):443-464.PubMedGoogle ScholarCrossref
19.
Krakowiak  P, Walker  CK, Bremer  AA,  et al.  Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders.  Pediatrics. 2012;129(5):e1121-e1128.PubMedGoogle ScholarCrossref
20.
Shevell  M.  Global developmental delay and mental retardation or intellectual disability: conceptualization, evaluation, and etiology.  Pediatr Clin North Am. 2008;55(5):1071-1084, xi.PubMedGoogle ScholarCrossref
21.
Srour  M, Shevell  M.  Genetics and the investigation of developmental delay/intellectual disability.  Arch Dis Child. 2014;99(4):386-389.PubMedGoogle ScholarCrossref
22.
Thomaidis  L, Zantopoulos  GZ, Fouzas  S, Mantagou  L, Bakoula  C, Konstantopoulos  A.  Predictors of severity and outcome of global developmental delay without definitive etiologic yield: a prospective observational study.  BMC Pediatr. 2014;14:40.PubMedGoogle ScholarCrossref
23.
Ananth  CV, Keyes  KM, Wapner  RJ.  Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis.  BMJ. 2013;347:f6564.PubMedGoogle ScholarCrossref
24.
Roberts  JM, Hubel  CA.  The two stage model of preeclampsia: variations on the theme.  Placenta. 2009;30(suppl A):S32-S37.PubMedGoogle ScholarCrossref
25.
Cha  J, Sun  X, Dey  SK.  Mechanisms of implantation: strategies for successful pregnancy.  Nat Med. 2012;18(12):1754-1767.PubMedGoogle ScholarCrossref
26.
Redman  CW, Sargent  IL.  Latest advances in understanding preeclampsia.  Science. 2005;308(5728):1592-1594.PubMedGoogle ScholarCrossref
27.
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy, American College of Obstetricians and Gynecologists.  Hypertension in Pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013.
28.
Neerhof  MG, Thaete  LG.  The fetal response to chronic placental insufficiency.  Semin Perinatol. 2008;32(3):201-205.PubMedGoogle ScholarCrossref
29.
Triunfo  S, Lobmaier  S, Parra-Saavedra  M,  et al.  Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion.  Placenta. 2014;35(6):398-403.PubMedGoogle ScholarCrossref
30.
Moore  GS, Kneitel  AW, Walker  CK, Gilbert  WM, Xing  G.  Autism risk in small- and large-for-gestational-age infants.  Am J Obstet Gynecol. 2012;206(4):314.e1-314.e9.PubMedGoogle Scholar
31.
Pinto-Martin  JA, Levy  SE, Feldman  JF, Lorenz  JM, Paneth  N, Whitaker  AH.  Prevalence of autism spectrum disorder in adolescents born weighing <2000 grams.  Pediatrics. 2011;128(5):883-891.PubMedGoogle ScholarCrossref
32.
Hertz-Picciotto  I, Croen  LA, Hansen  R, Jones  CR, van de Water  J, Pessah  IN.  The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism.  Environ Health Perspect. 2006;114(7):1119-1125.PubMedGoogle ScholarCrossref
33.
Bodnar  LM, Tang  G, Ness  RB, Harger  G, Roberts  JM.  Periconceptional multivitamin use reduces the risk of preeclampsia.  Am J Epidemiol. 2006;164(5):470-477.PubMedGoogle ScholarCrossref
34.
Zhang  J, Klebanoff  MA, Levine  RJ, Puri  M, Moyer  P.  The puzzling association between smoking and hypertension during pregnancy.  Am J Obstet Gynecol. 1999;181(6):1407-1413.PubMedGoogle ScholarCrossref
35.
Kalkbrenner  AE, Braun  JM, Durkin  MS,  et al.  Maternal smoking during pregnancy and the prevalence of autism spectrum disorders, using data from the Autism and Developmental Disabilities Monitoring Network.  Environ Health Perspect. 2012;120(7):1042-1048.PubMedGoogle ScholarCrossref
36.
Palmsten  K, Setoguchi  S, Margulis  AV, Patrick  AR, Hernández-Díaz  S.  Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?  Am J Epidemiol. 2012;175(10):988-997.PubMedGoogle ScholarCrossref
37.
Harrington  RA, Lee  LC, Crum  RM, Zimmerman  AW, Hertz-Picciotto  I.  Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.  Pediatrics. 2014;133(5):e1241-e1248.PubMedGoogle ScholarCrossref
38.
Pedersen  M, Stayner  L, Slama  R,  et al.  Ambient air pollution and pregnancy-induced hypertensive disorders: a systematic review and meta-analysis.  Hypertension. 2014;64(3):494-500.PubMedGoogle ScholarCrossref
39.
Greenland  S.  Modeling and variable selection in epidemiologic analysis.  Am J Public Health. 1989;79(3):340-349.PubMedGoogle ScholarCrossref
40.
Harrington  RA, Lee  LC, Crum  RM, Zimmerman  AW, Hertz-Picciotto  I.  Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.  Pediatrics. 2014;133(5):e1241-e1248.PubMedGoogle ScholarCrossref
41.
Walker  CK, Anderson  KW, Milano  KM,  et al.  Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism.  Biol Psychiatry. 2013;74(3):204-211.PubMedGoogle ScholarCrossref
42.
Kolevzon  A, Gross  R, Reichenberg  A.  Prenatal and perinatal risk factors for autism: a review and integration of findings.  Arch Pediatr Adolesc Med. 2007;161(4):326-333.PubMedGoogle ScholarCrossref
43.
Croen  LA, Grether  JK, Yoshida  CK, Odouli  R, Van de Water  J.  Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study.  Arch Pediatr Adolesc Med. 2005;159(2):151-157.PubMedGoogle ScholarCrossref
44.
Costantine  MM, Cleary  K; Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric-Fetal Pharmacology Research Units Network.  Pravastatin for the prevention of preeclampsia in high-risk pregnant women.  Obstet Gynecol. 2013;121(2, pt 1):349-353.PubMedGoogle Scholar
Original Investigation
February 2015

Preeclampsia, Placental Insufficiency, and Autism Spectrum Disorder or Developmental Delay

Author Affiliations
  • 1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, School of Medicine, University of California, Davis
  • 2Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California, Davis
  • 3Department of Public Health Sciences, School of Medicine, University of California, Davis
  • 4Department of Pediatrics, School of Medicine, University of California, Davis
  • 5Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis
JAMA Pediatr. 2015;169(2):154-162. doi:10.1001/jamapediatrics.2014.2645
Abstract

Importance  Increasing evidence suggests that autism spectrum disorder (ASD) and many forms of developmental delay (DD) originate during fetal development. Preeclampsia may trigger aberrant neurodevelopment through placental, maternal, and fetal physiologic mechanisms.

Objective  To determine whether preeclampsia is associated with ASD and/or DD.

Design, Setting, and Participants  The Childhood Autism Risks from Genetics and the Environment (CHARGE) study is a population-based, case-control investigation of ASD and/or DD origins. Children from 20 California counties aged 24 to 60 months at the time of recruitment and living in catchment areas with a biological parent fluent in English or Spanish were enrolled from January 29, 2003, through April 7, 2011. Children with ASD (n = 517) and DD (n = 194) were recruited through the California Department of Developmental Services, the Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, and referrals. Controls with typical development (TD) (n = 350) were randomly selected from birth records and frequency matched on age, sex, and broad geographic region. Physicians diagnosing preeclampsia were masked to neurodevelopmental outcome, and those assessing neurodevelopmental function were masked to preeclampsia status.

Exposures  Preeclampsia and placental insufficiency were self-reported and abstracted from medical records.

Main Outcomes and Measures  The Autism Diagnostic Observation Schedule and Autism Diagnostic Interview–Revised were used to confirm ASD, whereas children with DD and TD were confirmed by Mullen Scales of Early Learning and Vineland Adaptive Behavior Scales and were free of autistic symptoms. Hypotheses were formulated before data collection.

Results  Children with ASD were twice as likely to have been exposed in utero to preeclampsia as controls with TD after adjustment for maternal educational level, parity, and prepregnancy obesity (adjusted odds ratio, 2.36; 95% CI, 1.18-4.68); risk increased with greater preeclampsia severity (test for trend, P = .02). Placental insufficiency appeared responsible for the increase in DD risk associated with severe preeclampsia (adjusted odds ratio, 5.49; 95% CI, 2.06-14.64).

Conclusions and Relevance  Preeclampsia, particularly severe disease, is associated with ASD and DD. Faulty placentation manifests in the mother as preeclampsia with vascular damage, enhanced systemic inflammation, and insulin resistance; in the placenta as oxygen and nutrient transfer restriction and oxidative stress; and in the fetus as growth restriction and progressive hypoxemia. All are potential mechanisms for neurodevelopmental compromise.

×